Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2

Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism

(2019) Randy Yeh et al.   RADIOLOGY

Parathyroid imaging with 18F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study

(2019) Wouter A. M. Broos et al.   EJNMMI Research

18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients

(2018) Mohsen Beheshti et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Hyperparathyroidism

(2018) John P Bilezikian et al.   LANCET

F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study

(2017) Elske Quak et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop

(2014) John P. Bilezikian et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Dual-Phase 99mTc Sestamibi Scintigraphy With Neck and Thorax SPECT/CT in Primary Hyperparathyroidism

(2012) Renaud Ciappuccini et al.   CLINICAL NUCLEAR MEDICINE

Diagnostic randomized controlled trials: the final frontier

(2012) Marc Rodger et al.   Trials

A Meta-analysis of Preoperative Localization Techniques for Patients with Primary Hyperparathyroidism

(2011) Kevin Cheung et al.   ANNALS OF SURGICAL ONCOLOGY

The Superiority of Minimally Invasive Parathyroidectomy Based on 1650 Consecutive Patients With Primary Hyperparathyroidism

(2010) Robert Udelsman et al.   ANNALS OF SURGERY

Biokinetics of 18F-choline studied in four prostate cancer patients

(2010) H. Uusijarvi et al.   RADIATION PROTECTION DOSIMETRY

Preoperative 123I/99mTc-Sestamibi Subtraction SPECT and SPECT/CT in Primary Hyperparathyroidism

(2008) D. R. Neumann et al.   JOURNAL OF NUCLEAR MEDICINE